Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11291719 Methods and compositions for modulating Akt3

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

April 5, 2022

Patent Application Number

16989481

Date Filed

August 10, 2020

Patent Citations

US Patent 10342868 Methods and compositions for inhibiting Akt3

US Patent 10588966 Methods and compositions for inhibiting Akt3

US Patent 10525049 Specific Akt3 inhibitor and uses thereof

US Patent 10980878 Methods and compositions for modulating Akt3 activity

US Patent 10159731 Methods and compositions for inhibiting Akt3

US Patent 10292978 Specific Akt3 inhibitor and uses thereof

Patent Citations Received

US Patent 11957673 Specific AKT3 activator and uses thereof

0

Patent Primary Examiner

D Margaret M Seaman

CPC Code

Compounds and compositions for selectively modulating Akt3 are provided. Methods of using the compounds are also provided. Because Akt3 modulates the suppressive function of natural Tregs and the polarization of induced Tregs, the disclosed compounds are useful for modulating immune responses.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11291719 Methods and compositions for modulating Akt3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.